Provid Pharmaceuticals
Monmouth Junction
About Provid Pharmaceuticals
Provid was co-founded in 2001 by Drs. Gary Olson, Christopher Self, and Charles Cook, together with Profs. Amos B. Smith, III and Ralph Hirschmann of the University of Pennsylvania. The team has exceptional talent in synthetic and medicinal chemistry and includes world leaders in peptide and peptide mimetics technology and in structure-based drug design. Their experience makes Provid the premier drug discovery company for early stage research and translational drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Nov 2006)
- Website: provid.com
- Phone: (732) 565-1101
Industries & Categories
Pharmaceutical
Canonical: https://fsome.com/organization/provid-pharmaceuticals-2451105 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.